Amongst the total players offering bioassay services for cell and gene therapies, most of the players engaged in this domain were established before 1995. Of these, nine are headquartered in North America, while eight are based in Europe. Further, the industry witnessed the establishment of nine players, post 2010. Of these, five are based in North America, three in Europe and one in the Asia-Pacific region. In addition to this, all of the bioassay service providers (100%) are offering pre-developed assay. This is followed by 89% players that offer customized cell therapy assay and gene therapy assay. Primarily driven by the need for technical and operational expertise, which are available with contract service providers, the cell and gene therapy bioassay services market is poised to witness substantial growth in the coming years.
To request sample report please visit
Further, as can be observed from the figure, 75% service providers claim to have the required capabilities to offer services related to immunoassay. Besides this, we came across two companies which offer all the aforementioned bioanalytical services. Examples of such players include (in alphabetical order), BioAgilytix and PPD Laboratories. It is worth highlighting that, of the total companies offering bioassay services, close to 60% offer services both in vitro as well as in vivo type of bioassay for cell and gene therapies.
As the figure represents, majority are mid-sized players (48%). Of these, most (25%) of companies have been established between 2000 to 2010. This is followed by the large firms (36%), of which companies established before 1945 are (in reverse chronological order of year of establishment) BD Biosciences (1897), Lonza (1897), SGS (1878), Siemens Healthineers (1847) and Merck KGaA (1668).
Majority of the companies (89%) offer bioassay services for cell therapies, followed by 86% companies offering bioassay services for gene therapies. Further, immunoassay was found to be the most common bioanalytical service, provided by 75% companies. This is followed by potency assay and ELISA offered by 66% bioassay service providers.
For additional details, please visit
https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.html
You may also be interested in the following titles:
- Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
- Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
- Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030
- Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
- Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If youd like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
